Authors: Diep PT, Buemann B, Uvnas-Moberg K
PMID: 34908992 PMCID: PMC8629037 DOI: 10.36131/CNEPUB20201703
Abstract
After comparing the morbidity patterns of COVID-19 infections, variations of oxytocin levels and some properties of the neurohormone oxytocin, the authors put forward their hypothesis that oxytocin might constitute a safe, inexpensive and readily available treatment for this disease.
Keywords: COVID-19, pandemic; immune system; inflammation; oxytocin; treatment.
Source: https://pubmed.ncbi.nlm.nih.gov/34908992/
Archive: https://archive.is/C9JTl
